Option Care Health (NASDAQ:OPCH) Lowered to C+ at TheStreet

TheStreet downgraded shares of Option Care Health (NASDAQ:OPCHGet Rating) from a b rating to a c+ rating in a research note released on Thursday, TheStreetRatingsTable reports.

Other research analysts have also issued reports about the company. Barrington Research raised their price target on Option Care Health from $31.00 to $33.00 in a research report on Friday. Zacks Investment Research raised Option Care Health from a hold rating to a buy rating and set a $31.00 price target for the company in a report on Tuesday. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on Option Care Health from $32.00 to $39.00 in a report on Friday. Six equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has a consensus rating of Buy and an average price target of $31.17.

Shares of NASDAQ OPCH opened at $29.88 on Thursday. The firm has a market cap of $5.39 billion, a price-to-earnings ratio of 31.13, a price-to-earnings-growth ratio of 1.33 and a beta of 1.38. Option Care Health has a 52-week low of $16.02 and a 52-week high of $30.70. The company’s 50-day simple moving average is $27.32 and its 200-day simple moving average is $26.13. The company has a quick ratio of 1.15, a current ratio of 1.55 and a debt-to-equity ratio of 0.90.

Option Care Health (NASDAQ:OPCHGet Rating) last posted its earnings results on Thursday, April 28th. The company reported $0.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.13 by $0.04. Option Care Health had a return on equity of 10.07% and a net margin of 4.07%. The company had revenue of $915.78 million during the quarter, compared to analysts’ expectations of $839.45 million. During the same quarter last year, the firm earned ($0.02) earnings per share. The firm’s quarterly revenue was up 20.6% compared to the same quarter last year. Equities research analysts anticipate that Option Care Health will post 0.93 EPS for the current fiscal year.

In related news, COO Harriet Booker sold 6,000 shares of the business’s stock in a transaction dated Monday, February 7th. The stock was sold at an average price of $23.61, for a total value of $141,660.00. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders sold a total of 18,000 shares of company stock worth $461,460 in the last 90 days. 47.00% of the stock is currently owned by insiders.

Institutional investors have recently bought and sold shares of the stock. SG Americas Securities LLC lifted its holdings in Option Care Health by 107.2% in the first quarter. SG Americas Securities LLC now owns 26,635 shares of the company’s stock valued at $761,000 after acquiring an additional 13,779 shares during the period. Hillsdale Investment Management Inc. lifted its holdings in Option Care Health by 4.1% in the first quarter. Hillsdale Investment Management Inc. now owns 241,800 shares of the company’s stock valued at $6,906,000 after acquiring an additional 9,500 shares during the period. Comerica Bank lifted its holdings in Option Care Health by 1.1% in the first quarter. Comerica Bank now owns 64,017 shares of the company’s stock valued at $1,924,000 after acquiring an additional 690 shares during the period. Louisiana State Employees Retirement System lifted its holdings in Option Care Health by 2.0% in the first quarter. Louisiana State Employees Retirement System now owns 36,300 shares of the company’s stock valued at $1,091,000 after acquiring an additional 700 shares during the period. Finally, Strs Ohio lifted its holdings in Option Care Health by 15.7% in the first quarter. Strs Ohio now owns 44,900 shares of the company’s stock valued at $1,282,000 after acquiring an additional 6,100 shares during the period. Hedge funds and other institutional investors own 97.80% of the company’s stock.

About Option Care Health (Get Rating)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Further Reading

Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.